Why is Salzgitter stock surging today?

Salzgitter stock rose nearly 8.8% to trade at €47.62 after the company released preliminary nine-month 2026 results the prior evening and simultaneously lifted its full-year EBITDA guidance for the third time in 2026, raising the target range to €800–875 million from a prior €725–825 million.

The preliminary figures showed nine-month external revenue climbing to €7.3 billion from €6.9 billion a year earlier, while EBITDA surged to €659 million from just €224 million in the same period of 2025 — a performance that exceeded the average analyst consensus by roughly 30%. The company maintained its full-year revenue target of approximately €10 billion.

Two major Wall Street banks reinforced the bullish tone today. Jefferies kept its Buy rating and €66 price target, noting that around 80% of the EBITDA beat was attributable to the company’s at-equity stake in copper producer Aurubis AG, which contributed €252 million to nine-month earnings compared with only €83.5 million in the prior-year period.

JPMorgan analyst Dominic O’Kane similarly reaffirmed an Overweight rating with a €65 price target, highlighting the magnitude of the operating result beat relative to consensus. The stock led the MDax index during the session, reflecting the outsized nature of the earnings surprise.

The broader market environment provided a relatively neutral backdrop. Germany’s DAX edged fractionally higher on the day, while the MDax also posted a modest gain. European equities were trading cautiously ahead of the European Central Bank’s rate decision — widely expected to hold its deposit rate at 2.50% — and a key U.S. inflation release, meaning macro tailwinds played little role in Salzgitter’s sharp individual move.

Taken together, the combination of a major earnings beat, a third consecutive guidance upgrade, and prompt reaffirmation from influential sell-side analysts created a powerful and company-specific catalyst that drove Salzgitter to the top of the mid-cap index. The stock’s move also brought it meaningfully off its 52-week low of €26.66, though it remains well below its 52-week high of €67.60, leaving room for further recovery if the improved earnings trajectory continues into year-end.